HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

nadcin

a lyophilized mixture of NAD and inosine that may have used in treating hypoxia and ischemia

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Kavadze, I K: 1 article (09/2008)
2.	Sukoyan, G V: 1 article (09/2008)

Related Diseases

1.	Reperfusion Injury 09/01/2008 - "Effect of nadcin on energy supply system and apoptosis in ischemia-reperfusion injury to the myocardium."
2.	Ischemia 09/01/2008 - "Nadcin abolished the increase in poly-(ADP-ribose)-polymerase activity in the ischemic area of the right ventricle, nonischemic region, and ischemic area of the left ventricle (by 2.4, 2.9, and 1.52 times, respectively) and normalized bioenergetic activity of cardiomyocytes during ischemia-reperfusion myocardial injury." 09/01/2008 - "Nadcin in a dose of 90 mg/kg administered to dogs with subacute stage of ischemia-reperfusion myocardial injury immediately after blood flow resumption normalized redox potential of cardiomyocytes and mitochondria and restored the total content of adenyl and pyridine nucleotides. "

Related Drugs and Biologics

1.	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
2.	Nucleotides
3.	pyridine